Current Trials / Upcoming Trials

Have a question about our trials? Call us! 913-381-7180


Major Depression

Major Depression Study

FDA Approved

The objective of this study is to evaluate the efficacy, safety and tolerability of the drug an an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD who have had an inadequate response to antidepressants alone.

MUST BE 18 OR OLDER TO QUALIFY.

Other inclusion/exclusion standards apply. Call or Enroll to learn more.

Major Depression Study II

Study Drug: Pimavanserin

FDA Approved

The objective of this study is to evaluate the efficacy, safety of the drug compared to placebo in subjects with MDD that have an inadequate response to antidepressant therapy.

MUST BE 18 OR OLDER TO QUALIFY.

Other inclusion/exclusion standards apply. Call or Enroll to learn more.


Migraine

Migraine Study

This will be a parallel group, double-blind, randomized, placebo-controlled study assessing the efficacy of the drug for acute migraine, defined as an active intercurrent migraine occurring in those patients who are candidates for preventive therapy.

MUST BE 18 OR OLDER TO QUALIFY.

Other inclusion/exclusion standards apply. Call or Enroll to learn more.

Migraine Study II

This study will evaluate the safety and tolerability of the drug once a day for the prevention of migraine in participants with episodic migraine.

MUST BE 18 OR OLDER TO QUALIFY.

Other inclusion/exclusion standards apply. Call or Enroll to learn more.

Migraine Study III

This study is a randomized, double-blind, parallel group, placebo-controlled, to evaluate the efficacy, safety, and tolerability of single doses of the drug in the acute treatment of migraine.

MUST BE 18 OR OLDER TO QUALIFY.

Other inclusion/exclusion standards apply. Call or Enroll to learn more.


Fibromyalgia Study

This is a double-blind, randomized, placebo-controlled adaptive design trial to evaluate the efficacy and safety of the drug in Fibromyalgia.

MUST BE 18 OR OLDER TO QUALIFY.

Other inclusion/exclusion standards apply. Call or Enroll to learn more.


OCD

OCD Study

The purpose of this study is to compare the efficacy of the drug versus placebo in subjects with Obsessive Compulsive Disorder.

MUST BE 18 OR OLDER TO QUALIFY.

Other inclusion/exclusion standards apply. Call or Enroll to learn more.


PTSD

PTSD Study

FDA APPROVED

This study will be evaluating the efficacy, safety, and tolerability of the drug combination treatment in adult subjects with Post-Traumatic Stress Disorder.

MUST BE 18 OR OLDER TO QUALIFY.

Other inclusion/exclusion standards apply. Call or Enroll to learn more.

%d bloggers like this: